These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32927497)

  • 41. An intrinsic, label-free signal for identifying stem cell-derived cardiomyocyte subtype.
    Chang CW; Kao HKJ; Yechikov S; Lieu DK; Chan JW
    Stem Cells; 2020 Mar; 38(3):390-394. PubMed ID: 31778240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Electrical stimulation applied during differentiation drives the hiPSC-CMs towards a mature cardiac conduction-like cells.
    Crestani T; Steichen C; Neri E; Rodrigues M; Fonseca-Alaniz MH; Ormrod B; Holt MR; Pandey P; Harding S; Ehler E; Krieger JE
    Biochem Biophys Res Commun; 2020 Dec; 533(3):376-382. PubMed ID: 32962862
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Yohimbine Directly Induces Cardiotoxicity on Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Gong Y; Yang L; Tang J; Zheng J; Witman N; Jakob P; Tan Y; Liu M; Chen Y; Wang H; Fu W; Wang W
    Cardiovasc Toxicol; 2022 Feb; 22(2):141-151. PubMed ID: 34817810
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents.
    Ma J; Guo L; Fiene SJ; Anson BD; Thomson JA; Kamp TJ; Kolaja KL; Swanson BJ; January CT
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2006-17. PubMed ID: 21890694
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Disruption of histamine/H
    Zhu X; Ding S; Li H; Zhang Z; Xu L; Wu J; Wang X; Zou Y; Yang X; Ge J
    Stem Cell Res Ther; 2020 Mar; 11(1):27. PubMed ID: 32127042
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiomyocyte functional screening: interrogating comparative electrophysiology of high-throughput model cell systems.
    Wells SP; Waddell HM; Sim CB; Lim SY; Bernasochi GB; Pavlovic D; Kirchhof P; Porrello ER; Delbridge LMD; Bell JR
    Am J Physiol Cell Physiol; 2019 Dec; 317(6):C1256-C1267. PubMed ID: 31577512
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Small molecule-mediated directed differentiation of human embryonic stem cells toward ventricular cardiomyocytes.
    Karakikes I; Senyei GD; Hansen J; Kong CW; Azeloglu EU; Stillitano F; Lieu DK; Wang J; Ren L; Hulot JS; Iyengar R; Li RA; Hajjar RJ
    Stem Cells Transl Med; 2014 Jan; 3(1):18-31. PubMed ID: 24324277
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CRISPR/Cas9-based targeting of fluorescent reporters to human iPSCs to isolate atrial and ventricular-specific cardiomyocytes.
    Chirikian O; Goodyer WR; Dzilic E; Serpooshan V; Buikema JW; McKeithan W; Wu H; Li G; Lee S; Merk M; Galdos F; Beck A; Ribeiro AJS; Paige S; Mercola M; Wu JC; Pruitt BL; Wu SM
    Sci Rep; 2021 Feb; 11(1):3026. PubMed ID: 33542270
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A critical role of retinoic acid concentration for the induction of a fully human-like atrial action potential phenotype in hiPSC-CM.
    Schulz C; Sönmez M; Krause J; Schwedhelm E; Bangfen P; Alihodzic D; Hansen A; Eschenhagen T; Christ T
    Stem Cell Reports; 2023 Nov; 18(11):2096-2107. PubMed ID: 37922915
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Geometrical Patterning and Constituent Cell Heterogeneity Facilitate Electrical Conduction Disturbances in a Human Induced Pluripotent Stem Cell-Based Platform: An
    Nakanishi H; Lee JK; Miwa K; Masuyama K; Yasutake H; Li J; Tomoyama S; Honda Y; Deguchi J; Tsujimoto S; Hidaka K; Miyagawa S; Sawa Y; Komuro I; Sakata Y
    Front Physiol; 2019; 10():818. PubMed ID: 31316396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Deep phenotyping of human induced pluripotent stem cell-derived atrial and ventricular cardiomyocytes.
    Cyganek L; Tiburcy M; Sekeres K; Gerstenberg K; Bohnenberger H; Lenz C; Henze S; Stauske M; Salinas G; Zimmermann WH; Hasenfuss G; Guan K
    JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925689
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification and purification of human induced pluripotent stem cell-derived atrial-like cardiomyocytes based on sarcolipin expression.
    Josowitz R; Lu J; Falce C; D'Souza SL; Wu M; Cohen N; Dubois NC; Zhao Y; Sobie EA; Fishman GI; Gelb BD
    PLoS One; 2014; 9(7):e101316. PubMed ID: 25010565
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacological enhancement of repolarization reserve in human induced pluripotent stem cells derived cardiomyocytes.
    Treat JA; Goodrow RJ; Bot CT; Haedo RJ; Cordeiro JM
    Biochem Pharmacol; 2019 Nov; 169():113608. PubMed ID: 31465775
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of In Vitro Drug-Induced Cardiotoxicity Assay by Using Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells.
    Takeda M; Miyagawa S; Fukushima S; Saito A; Ito E; Harada A; Matsuura R; Iseoka H; Sougawa N; Mochizuki-Oda N; Matsusaki M; Akashi M; Sawa Y
    Tissue Eng Part C Methods; 2018 Jan; 24(1):56-67. PubMed ID: 28967302
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Availability of a novel cardiotoxicity evaluation system using human induced pluripotent stem cell-derived atrial-like myocytes].
    Honda Y
    Nihon Yakurigaku Zasshi; 2020; 155(5):303-308. PubMed ID: 32879170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Simulation of cardiac arrhythmias in human induced pluripotent stem cell-derived cardiomyocytes.
    Bommer T; Knierim M; Unsöld J; Riedl D; Stengel L; Paulus M; Körtl T; Liaw N; Maier LS; Streckfuss-Bömeke K; Sossalla S; Pabel S
    PLoS One; 2024; 19(9):e0310463. PubMed ID: 39331676
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Comparative Assessment of Marker Expression Between Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells and the Developing Pig Heart.
    Lauschke K; Volpini L; Liu Y; Vinggaard AM; Hall VJ
    Stem Cells Dev; 2021 Apr; 30(7):374-385. PubMed ID: 33599158
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of FDSS/μCell imaging platform for preclinical cardiac electrophysiology safety screening of compounds in human induced pluripotent stem cell-derived cardiomyocytes.
    Zeng H; Roman MI; Lis E; Lagrutta A; Sannajust F
    J Pharmacol Toxicol Methods; 2016; 81():217-22. PubMed ID: 27222351
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modeling Reentry in the Short QT Syndrome With Human-Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets.
    Shinnawi R; Shaheen N; Huber I; Shiti A; Arbel G; Gepstein A; Ballan N; Setter N; Tijsen AJ; Borggrefe M; Gepstein L
    J Am Coll Cardiol; 2019 May; 73(18):2310-2324. PubMed ID: 31072576
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calcium homeostasis in human induced pluripotent stem cell-derived cardiomyocytes.
    Lee YK; Ng KM; Lai WH; Chan YC; Lau YM; Lian Q; Tse HF; Siu CW
    Stem Cell Rev Rep; 2011 Nov; 7(4):976-86. PubMed ID: 21614516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.